September is World Alzheimer’s Month. The purpose of this campaign is to raise awareness and challenge the stigma that surrounds dementia.

Some of the symptoms of this brain disease include:

  • slowed thinking
  • occasional or persistent memory problems
  • disorientation
  • unexpected mood and behavior changes
  • confusion about events, time and place
  • difficulty speaking, swallowing and walking

Both GCT President, Dr. Jeffrey Apter and CEO, Dr. Eugene Selivra are trained psychiatrists with 50+ years of combined experience in clinical research. Dr. Apter is a KOL in Alzheimer’s Disease. For more than 19 years GCT has been focusing on conducting trials in CNS and Neurology, including the Alzheimer’s Disease indication.

Patients with Alzheimer’s disease may find it hard to recognize the problem. Nevertheless, we can assist through raising awareness.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.